Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Tissue vaccines are composed of material harvested directly from tumors. Tissue vaccines include antigens associated with neoplastic cells and with the tumor stroma. Furthermore, they include ...

Chimeric antigen receptor-T (CAR-T) cell therapy ... Autopsies indicated that CAR T cells had accumulated within the lung tissue, particularly in benign pulmonary epithelial cells. The observed ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Guillain-Barré Syndrome is an uncommon, rare neurological condition in which the immune system mistakenly attacks the body's ...

Immutep Limited (IMMP) is a promising biotech stock with a strong pipeline and solid financial foundation, making it a buy ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

"Recycling" an already transplanted organ could help save lives, but the procedure comes with additional risks, physicians ...